Putnam Investments LLC Denali Therapeutics Inc. Transaction History

Putnam Investments LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	SELL	$25.97 - $38.53 $6,025 - $8,938	-232 Reduced 0.36%	64,044 $1.97 Million
Q2 2022 Aug 15, 2022	BUY	$20.88 - $35.19 $6,953 - $11,718	333 Added 0.52%	64,276 $1.89 Million
Q1 2022 May 16, 2022	SELL	$29.0 - $47.27 $374,593 - $610,586	-12,917 Reduced 16.81%	63,943 $2.06 Million
Q4 2021 Feb 14, 2022	BUY	$42.59 - $55.02 $219,721 - $283,848	5,159 Added 7.2%	76,860 $3.43 Million
Q3 2021 Nov 15, 2021	SELL	$48.48 - $78.23 $824 - $1,329	-17 Reduced 0.02%	71,701 $3.62 Million
Q2 2021 Aug 16, 2021	BUY	$50.3 - $78.44 $4,929 - $7,687	98 Added 0.14%	71,718 $5.63 Million
Q1 2021 May 17, 2021	BUY	$53.8 - $81.53 $1.37 Million - $2.08 Million	25,538 Added 55.42%	71,620 $4.09 Million
Q4 2020 Feb 16, 2021	BUY	$36.89 - $93.56 $1.7 Million - $4.31 Million	46,082 New	46,082 $3.86 Million

237

111M

80K

36.8K

Ticker DNLI
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 134,174,000
Market Cap $1.98B
Description
Denali Therapeutics Inc., a biopharmaceutical company, discovers and develops therapeutic candidates for neurodegenerative diseases in the United States. It offers leucine-rich repeat kinase 2 (LRRK2) inhibitor product candidate, including BIIB122/DNL151, a small molecule inhibitor, which is in phase I and phase Ib clinical trials for the treatm...

Get notified when there are updates to the investment portfolio of Putnam Investments LLC, based on Form 13F filings with the SEC.

Stay updated on Putnam Investments LLC with notifications on news.